Virually all cultures have, throughout history, used a variety of plants or materials derived from plants for the prevention and treatment ofdisease. Evidence of the beneficial therapeutic effects of these medial herbs is seen in their continued use. Additionally, the development of modern chemistry permitted the isolation of chemnicals from medicinal herbs that have served as drugs or starting materials for the synthesis of many important drugs used today. Many more modern drugs have been synthesized as a result of knowledge gained from studies of mechanisms of actions of chemicals first isolated from medicinal herbs. Thus, medicinal herbs have played a major role in the development of modern medicine and continue to be widely used in their original form. Whereas it is generally agreed that most medicinal herbs are safe under the conditions used, some are toxic and should be avoided even though they are readily available, and others have significant adverse side effects when misused. Also, little has been done to investigate potential adverse effects that may be associated with extended or high-dose use of medicinal herbs.
Thus, concern has been expressed that the lack of quality control used in the preparation of medicinal herbs, plus their unregulated sale and uninformed use, pose potential adverse health effects for consumers. There is also concer regarding potential herblherb or herbldrug interactions and possible untoward health effects of medicinal herbs in sensitive subpopulations such as the young and the elderly and certain genetically predisposed individuals. In this paper, we discuss these concerns at some length and make recommendations for additional research and education dis- (9) . Also, because they are not regulated for content or efficacy, it is not possible to know how often medicinal herbs fail to contain the advertised active ingredient and thus have no effect. It is also impossible to determine when a product might have contained substances that resulted in subtle adverse effects that were not reported. Similarly, it is quite possible that the placebo effect resulting from widespread advertising, popular promotion, and the natural tendency of most common maladies to run their course accounts for much of the beneficial effects achieved with some products.
Other concerns regarding the use of medicinal herbs include the possibility of herb/herb or herb/drug interactions and allergic reactions (7) (8) (9) (12) . Concern for the possibility of adverse drug/herb reactions is heightened by the fact that the potential for such interactions is not described on the package inserts for most prescription drugs, and herbal remedies do not require package inserts. Thus, because the consumer is uninformed and many patients do not inform their physicians that they are also using medicinal herbs, the potential for adverse interaction is increased.
Recommendations for the use of prescribed drugs (i.e., dose, manner, and frequency of administration and the period for which they are taken) are reviewed and controlled by the prescribing physician. Because they are usually self-prescribed by the consumer, this is frequently not the case with medicinal herbs. Further, the extended preclinical and clinical testing to assure the safety of prescription drugs before they are released to the market is not required for medicinal herbs. Little is known about chronic toxicities that might be associated with their prolonged use. There has been minimal research to address possible adverse reproductive, immunologic, or neurologic Volume 107, Number 10, October 1999 * Environmental Health Perspectives effects or even systemic toxicity and/or carcinogenicity that might be associated with high doses or prolonged use of these products (10) . This concern was frequently expressed at the International Workshop to Evaluate Research Needs on the Use and Safety of Medicinal Herbs, where it was strongly emphasized that medicinal herbs cannot be assumed safe because they are "natural" (3). Many natural products are quite toxic or carcinogenic. For example, strychnine (one of the most toxic chemicals known), aflatoxin (which is both toxic and carcinogenic), and pulegone (a toxic abortifacient) are all "natural" (8, 9) . Pulegone is found in the medicinal herb pennyroyal, which can be found in many outlets for medicinal herbs. Medicinal herbs contain a variety of chemicals that are toxic when consumed at high doses and for which little is known about their chronic toxicity. Because the DSHEA exempts dietary supplements such as medicinal herbs from testing (6), the public may be unknowingly exposed to chemicals with the potential to induce a variety of toxicities and/or carcinogenicity on chronic use. Further, because such testing is expensive and is not required, it is unlikely to be performed by the producers or distributors of these products. This does not mean that the industry is not interested in the safety of their products. Rather, as best described by Loren Israelson (3), a spokesperson for the herbal industry, there is a financial disincentive for the industry to support such research. Because these products cannot be patented, funding research into their chronic effects would not confer any proprietary right to the company that supported the work. Thus, research funded by one company could be used equally well by their competitors.
Other concerns regarding the marketing and use of medicinal herbs voiced both in the literature and at the recent workshop are those of standardization and stability (1-3). Unlike pharmaceuticals, botanical products are complex mixtures in which the active ingredients may not be known or may constitute only a small percent of the total product. Some products are, in fact, believed to achieve their beneficial effects through the combined actions of several ingredient chemicals, each of which accounts for a very small portion of the total product. Quality control issues are further complicated by the manner in which these products are produced. That is, unlike synthetic drugs that are produced in highly purified form, medicinal herbs are gathered in the wild or grown in relatively small plots. Thus, the active ingredients may vary significantly with the part of the plant used, the season in which they are harvested, and/or the growing conditions (e.g., weather, soil, etc.). When these facts are combined with the fact that these dried plant parts are purchased locally by dealers who sell them to the larger distributor, who in turn may further market or formulate and distribute the final product, the potential for misidentification or cross contamination is apparent. Because little is done to monitor the concentration of active ingredients or the possibility of cross contamination through these steps, the content of active ingredients in a given product may vary significantly from one lot to another.
As
of medicinal herbs. Quality control guidelines based on methods described in pharmacopoeias from more than a dozen nations have been described in a recent document prepared by the World Health Organization (WXHO) (13) . A recent effort by the U.S. Pharmacopeia has provided more detailed methods for the standardization of specific medicinal herbs and dietary supplements (14) . Monographs for the specific herbs addressed are being published as they are developed. These methods are only recommended, however, and are not required for any of the products addressed.
As mentioned above, the active ingredients of herbal formulations usually constitute a small fraction of the total product. In some cases, the active ingredient(s) are unknown or only partially characterized. In other cases, beneficial effects are attributed to a combination of active ingredients. Because the stability of chemicals varies according to individual structures of the chemicals and the formulation in which they are found, the stability of active ingredients of medicinal herbs is also a matter of concern. However, the active ingredients of many medicinal herbs are unknown, and for others our knowledge of active ingredients is incomplete. Thus, expiration dates, when present for medicinal herbs, may not be meaningful. Because 20 -fold. Further, the content of ginsenosides did not necessarily vary in proportion to the weight of ginseng in the capsule. In addition to better standardization of the products, work is needed to confirm the stability of the active ingredient(s) of medicinal herbs. In the absence of adequate standardization and quality control, both consumers and responsible producers of medicinal herbs are at risk. Consumers must have a consistent product of high quality to effectively achieve safe, beneficial effects from one formulation to another. Responsible producers are at risk when inconsistent or ineffective products damage the reputation of the industry.
Recommendations. Where methods for such quality assurance are available, they should be employed industry wide. When such methods are lacking, research should be undertaken by both the industry and government to identify, certify, and quantify active ingredients and to determine and recommend optimum doses of medicinal herbs.
Formulations of medicinal herbs should be standardized, to the extent possible, to deliver a known amount of the active ingredient(s) in a recommended dose. Where they are known, the stability of the active ingredients should be determined, and all packages should carry meaningful expiration dates.
Package inserts that contain dear instructions regarding doses and possible contraindications should be prepared and required for medicinal herbs.
Action. As discussed earlier, 'WHO (13) has developed basic methods for the analysis of medicinal herbs, and the U.S. Pharmacopeia (14) is developing and publishing recommended methods for specific herbal formulations. As described by Joe Betz and William R. Obermeyer at the workshop, research at the FDA is currently addressing the need for improved methods to ensure the content and quality of medicinal herbs. Jill Ellis of the National Nutritional Foods Association and Loren Israelsen, of the Utah Natural Products Alliance, two representatives of the medicinal herb industry in attendance at the workshop, emphasized that many components of the industry are working to better standardize their products. The entry of the major pharmaceutical houses into the medicinal herb market is speculated to result in more consistent formulations.
Consumer Education
The American public, overall, comprises a well-educated and sophisticated group of consumers. However, any consumer group must base buying decisions on available information. In the case of medicinal herbs, information about health benefits has been largely limited to that provided by a relatively few advocates of their use and marketers of these products. Thus, most of the available information has been limited to the positive aspects associated with the use of medicinal herbs, with little, if any, discussion of possible adverse effects. The general public is largely unaware that adverse health effects associated with the use of medicinal herbs have been attributed to everything from overdosing to contaminated formulations to the inherent toxicity of the herb of choice. The public is also largely unaware that much of the literature regarding the beneficial effects of these compounds is anecdotal, may be greatly exaggerated or incorrect, and has yet to be confirmed through clinical trials. Most of the clinical trials that have been conducted have been conducted in other countries, and in most cases, the results have not been translated into English or evaluated by U.S. regulatory officials. Thus, when it comes to medicinal herbs, the American public may not be welleducated consumers.
Recommendations. Because these products are not proprietary but are being consumed by a large segment of the public, federal funds should be used to develop, evaluate, and distribute the most authoritative information available regarding the efficacy and safety of herbal formulations.
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